The challenge to UK drug policy

Drugs: Education, Prevention and Policy

Volumn 14, Issue 6, 2007, Pages 559-571

  McKeganey, Neil ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36549076910     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.1080/09687630701538766     Document Type: Article

References (30)

1. Amato, L., Davoli, M., Perruci, C., Ferri, M., Faggiano, F., & Mattick, R. (2005). An overview of systematic evidence reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28, 321-329.
2. Bloor, M., Neale, J., & McKeganey, N. (2006). Persisting local variations in prevalence of hepatitis C virus among Scottish problem drug users: Results from an anonymous screening study. Drugs: Education, Prevention and Policy, 13, 189-191.
3. Bruneau, J., Franco, E., Lamothe, F., Lachance, N., Desy, M., & Soto, J. (1997). High rates of HIV infection among injecting drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146(12), 994-1002.
4. Gruer, L., Cameron, J., & Elliot, L. (1993). Building a city wide network for exchanging needles and syringes. British Medical Journal, 306, 1394-1397.
5. Hall, W., & Degenhardt, L. (2000). Cannabis use and psychosis: A review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 43, 26-34.
6. Hall, W., & Solowji, L. (1998). The adverse effects of cannabis. Lancet, 352, 1611-1616.
7. Hay, G., Gannon, M., MacDougal, J., Millar, T., Eastwood, C., McKeganey, N. (2007). Local and national estimates of the prevalence of opiate use and/or crack cocaine use (2004/05). In Sigleton, M., Murray, R., Tinsley, L. (2007). Measuring different aspects of problem drug use: methodological developments. Home Office online Report 16/06.
8. Health Protection Agency. (2005). Shooting Up Infections Among Injecting Drug Users in the United Kingdom 2004. London Health Protection Agency.
9. Home Office. (2002). Updated drug strategy. London: The Home Office.
10. House of Commons. (2006). Science and technology committee fifth report. London: Staionary Office.
11. International Working Group (2006). The report of the independent working group on drug consumption rooms. York, UK: Joseph Rowntree Foundation.
12. Lloyd, C., & Hunt, N. (2007). Drug consumption rooms: An overdue extension to harm reduction policy in the UK. International Journal of Drug Policy, 18, 5-9.
13. McKeganey, N. (2006). The lure and loss of harm reduction. Addiction Research and Theory, 14, 557-588.
14. Morgan, O., Griffiths, C., Tuson, B., Rooney, C., Majeed, A., & Hickman, M. (2007). Trends in deaths related to drug misuse England and Wales 1993-2004. Health Statistics Quarterly, Autumn 2006. London: National Statistics.
15. Moss, A. (2000). Epidemiology and the politics of needle exchange. American Journal of Public Health, 90(9), 1385-1388.
16. Nutt, D., King, L., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harms of drugs of potential misuse. Lancet, 369, 1047-1053.
17. Reuter, P., & Stevens, A. (2007). An analysis of UK drug policy: A monograph prepared for the UK Drug Policy Commission. London: UK Drug Comission Policy.
18. Rey, J., Sawer, M., Raphael, B., Patton, G., & Lynskey, M. (2002). Mental health of teenagers who use cannabis: Results of an Australian survey. British Journal of Psychiatry, 180, 216-221.
19. Rey, J., & Tennant, C. (2002). Editorial: Cannabis and mental health. British Medical Journal, 325, 1183-1184.
20. Royal Society of Arts. (2007). Drugs facts: The report of the RSA Commission on illegal drugs communities and public policy. London: RSA.
21. Scottish Executive, Information and Statistics Division. (2005). How many people are receiving methadone hydrochloride mixture for opiate dependence in Scotland and what are the prescribing costs per person. (Available at: www.drugmisuse.isdscotland.org/publications/local/isd_methadone.pdf).
22. Uchtenhagen, A., Dobler-Mikola, A., & Gutzwiller, F. (1996). Medical prescription of narcotics: Background and intermediate results of a Swiss national project. European Research Journal, 2, 201-207.
23. Uchtenhagen, A., Dobler-Mikola, A., & Steffen, A. (1997). A programme for a medical prescription of narcotics. A synthesis of results. European Addiction Research, 3, 160-163.
24. Uchtenhagen, A., Dobler-Mikola, A., Steffen, T., Gutzwiller, F., Blatter, R., & Pfeifer, S. (1999). Prescription of narcotics for heroin addicts. Main results of Swiss national cohort study. Vol. 1: Medical prescription of narcotics. Basel, Switzerland: Karger.
25. UK Government. (1998). Tackling drugs to build a better Britain: The governments 10-year strategy for tackling drugs misuse.. London: Stationery Office.
26. Van den Brink, W., Hendriks, V., & Van Ree, J. (1999). Medical co-prescription of heroin to chronic treatment resistant methadone patients in the Netherlands. Journal of Drug Issues, 29, 587-608.
27. Van den Brink, W., Vincent, M., Hendriks, V., Blanken, P., Huijsman, I., & Van Ree, J. (2002). Medical co-prescription of heroin. Two randomized controlled trials. Utrecht, The Netherlands: Central Committee on the Treatment of Heroin Addicts.
28. Vertefeuille, J., Marx, M. A., Tun, W., Huettner, S., Strathdee, S. A., & Vlahov, D. (2000). Decline in Self-Reported High Risk Injection-Related Behaviors Among HIV Seropositive Participants in the Baltimore Needle Exchange Program. AIDS and Behavior, 4, 381-388.
29. Vlahov, D. Junge, B., Brookmeyer, R., Cohn, S., Riley, E., Amenian, H., Beilenson, P. (1997). Reductions in High Risk Drug Use Behaviours Amongst Participants in the Baltimore Needle Exchange Prgramme. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16(5), 400-406.
30. Wodak, A., & Cooney, S. (2004). Effectiveness of sterile needle and syringe programmes in reducing HIV/AIDS among injecting drug users: Evidence for action (Technical Papers). Geneva, Switzerland: World Health Organization.